| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |